Burcon NutraScience Statistics
Total Valuation
BRCND has a market cap or net worth of 28.19 million. The enterprise value is 39.24 million.
| Market Cap | 28.19M |
| Enterprise Value | 39.24M |
Important Dates
The last earnings date was Thursday, June 26, 2025.
| Earnings Date | Jun 26, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 12.69M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +28.83% |
| Shares Change (QoQ) | +39.29% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 106.23 |
| PB Ratio | 5.83 |
| P/TBV Ratio | 7.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -6.82 |
| EV / Sales | 140.78 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -9.70 |
Financial Position
The company has a current ratio of 1.82, with a Debt / Equity ratio of 3.23.
| Current Ratio | 1.82 |
| Quick Ratio | 1.72 |
| Debt / Equity | 3.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -3.85 |
| Interest Coverage | -12.14 |
Financial Efficiency
Return on equity (ROE) is -136.64% and return on invested capital (ROIC) is -23.38%.
| Return on Equity (ROE) | -136.64% |
| Return on Assets (ROA) | -22.09% |
| Return on Invested Capital (ROIC) | -23.38% |
| Return on Capital Employed (ROCE) | -29.20% |
| Revenue Per Employee | 17,690 |
| Profits Per Employee | -383,334 |
| Employee Count | 15 |
| Asset Turnover | 0.02 |
| Inventory Turnover | 9.29 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 42.89 |
| Average Volume (20 Days) | 4,743 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BRCND had revenue of 265,347 and -5.75 million in losses. Loss per share was -0.74.
| Revenue | 265,347 |
| Gross Profit | -605,812 |
| Operating Income | -5.36M |
| Pretax Income | -5.75M |
| Net Income | -5.75M |
| EBITDA | -5.17M |
| EBIT | -5.36M |
| Loss Per Share | -0.74 |
Balance Sheet
The company has 5.06 million in cash and 15.58 million in debt, giving a net cash position of -10.52 million.
| Cash & Cash Equivalents | 5.06M |
| Total Debt | 15.58M |
| Net Cash | -10.52M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.83M |
| Book Value Per Share | 0.38 |
| Working Capital | 2.44M |
Cash Flow
In the last 12 months, operating cash flow was -3.84 million and capital expenditures -211,134, giving a free cash flow of -4.05 million.
| Operating Cash Flow | -3.84M |
| Capital Expenditures | -211,134 |
| Free Cash Flow | -4.05M |
| FCF Per Share | n/a |
Margins
| Gross Margin | -228.31% |
| Operating Margin | -2,018.75% |
| Pretax Margin | -2,166.98% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
BRCND does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -28.83% |
| Shareholder Yield | n/a |
| Earnings Yield | -20.40% |
| FCF Yield | -14.36% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 11, 2025. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jun 11, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
BRCND has an Altman Z-Score of -6.92 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.92 |
| Piotroski F-Score | 3 |